Colorectal Cancer
European societies release joint guideline for use of FIT in colorectal cancer diagnosis
The Association of Coloproctology of Great Britain and Ireland and the British Society of Gastroenterology have published a joint guideline for the strategic use of fecal immunochemical testing in people with suspected colorectal cancer.
Researchers identify higher rates of young-onset CRC mortality in Midwest, Great Lakes regions
Researchers have discovered geographic patterns of mortality rates among patients with young-onset colorectal cancer in the United States, according to findings published in Gastroenterology.
VIDEO: No survival benefit of resecting asymptomatic primary tumor
In this video Michael Cecchini, MD discussed study presented at ASCO that "puts to rest" whether asymptomatic primary tumors in patients with metastatic colorectal cancer should be resected.
Preventative Measures and New Technology’s Impact on Colon Cancer Screening with Guido Baechler
In this episode, Guido Baechler discusses the pandemic’s impact on healthcare and preventative health, personalizing cancer care after diagnosis and more.
Screening declines after pandemic onset may result in ‘increased avoidable cancer deaths’
Widespread reductions in cancer screenings during the COVID-19 pandemic may be associated with delayed cancer diagnoses and increased mortality for breast, cervical and colon cancers, according to study results published in JAMA Oncology.
Top in hem/onc: Cell therapy approaches; low colorectal cancer screening rates
Strategies for cell therapy to treat cancer very depending on the type of tumor, according to experts.
VIDEO: Insight into FOLFOXIRI plus panitumumab for certain patients with colorectal cancer
In this video, Michael Cecchini, MD, discussed a late-breaking abstract evaluating FOLFOXIRI plus panitumumab vs. mFOLFOX6 plus panitumumab as initial treatment of unresectable RAS and BRAF wild-type metastatic colorectal cancer.
VIDEO: COMMIT study accruing first-line patients with MSI-high colorectal cancer
In this video, Howard S. Hochester, MD, discusses the COMMIT study comparing the anti-PD1 drug atezolizumab with atezolizumab combined with FOLFOX chemotherapy presented as part of a poster session at ASCO Annual Meeting.
Top Headlines in Breast Cancer: diagnoses increase post-pandemic; hair products increase breast cancer risk; and more
In this edition, late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic; chemicals found in hair products increase viability of breast cancer cells in Black women; continued CDK 4/6 inhibition after breast cancer progression may benefit some patients; and more.
Colorectal cancer screening prevalence remains low among younger adults
Colorectal cancer screening prevalence remained low in 2018 among U.S. adults aged 50 to 54 years vs. 70 to 75 years, with the younger group exhibiting larger disparities by race/ethnicity, education level, income and insurance.